Lonza News ٩ أبريل ٢٠٢٦ Lonza Redefines Bioprocess Efficiency In APAC With Advanced Media Development Lab - BioSpectrum Asia
Lonza News ٨ أبريل ٢٠٢٦ Lonza Group AG stock: What investors need to know for long-term growth - AD HOC NEWS
Lonza News ٨ أبريل ٢٠٢٦ ImmuneOncia signs manufacturing agreement with Lonza for Danburstotug - Drug Discovery News
Lonza News ٧ أبريل ٢٠٢٦ Lonza Nominates Stephen Fry as Independent Board Member - Manufacturing Chemist
Lonza News ٧ أبريل ٢٠٢٦ Swiss Rockets collaborates with Lonza to advance Torqur’s oncology drug candidate bimiralisib into late-stage clinical development - Manufacturing Chemist
Lonza News ٦ أبريل ٢٠٢٦ Lonza Group AG stock: What investors should know about its biotech edge now - AD HOC NEWS
Lonza News ٢ أبريل ٢٠٢٦ Formulating Plant-Based and Organic Supplements: A Conversation with Lonza CHI - Nutritional Outlook
Lonza News ٢ أبريل ٢٠٢٦ Swiss Rockets Collaborates with Lonza to Advance Torqur’s Oncology Drug Candidate Bimiralisib into Late-Stage Clinical Development - the-scientist.com
Lonza News ٢ أبريل ٢٠٢٦ Lonza to manufacture ImmuneOncia’s antibody for rare type of lymphoma - BioProcess International
Lonza News ٢ أبريل ٢٠٢٦ ImmuneOncia Therapeutics and Lonza collaborate to manufacture Danburstotug - Manufacturing Chemist
Lonza News ١ أبريل ٢٠٢٦ Lonza Group (SWX:LONN) Is Up 5.8% After 25% Dividend Hike And Board Refresh - Has The Bull Case Changed? - simplywall.st
Lonza News ١ أبريل ٢٠٢٦ Lonza: Growth Intact, CHI Exit Strengthens Focus, Recent Dip Opens Opportunity (LZAGY) - Seeking Alpha